Cargando…

Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method

Vitamin K antagonists, such as warfarin, have a narrow therapeutic window; patients on these therapies therefore require regular international normalized ratio (INR) monitoring to maintain optimal dosing. This involves periodic checks and laboratory testing using venepuncture, which are often percei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tait, Robert Campbell, Hung, Annielle, Gardner, Roy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019395/ https://www.ncbi.nlm.nih.gov/pubmed/31773973 http://dx.doi.org/10.1177/1076029619890423

Ejemplares similares

Performance Evaluation of the Quantitative Point-of-Care LumiraDx d-Dimer Test
por: Ellis, Jayne E., et al.
Publicado: (2021)

Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children
por: Drain, Paul, et al.
Publicado: (2021)

Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19
por: Gresh, Jared, et al.
Publicado: (2021)

Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
por: Krüger, Lisa J., et al.
Publicado: (2021)

Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant
por: Karon, Brad S., et al.
Publicado: (2023)

LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms
por: Ellis, Jayne E., et al.
Publicado: (2022)

Rapid Antigen Test LumiraDx(TM) vs. Real Time Polymerase Chain Reaction for the Diagnosis of SARS-CoV-2 Infection: A Retrospective Cohort Study
por: Cattelan, Anna Maria, et al.
Publicado: (2022)

Extraction-Free Detection of SARS-CoV-2 Viral RNA Using LumiraDx’s RNA Star Complete Assay from Clinical Nasal Swabs Stored in a Novel Collection and Transport Medium
por: Daum, Luke T., et al.
Publicado: (2023)

Usefulness of the Lumiradx™ SARS-COV-2 antigen test in nursing home()
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Effects of oral anticoagulation with various INR levels in deep vein thrombosis cases
por: Yetkin, Ufuk, et al.
Publicado: (2004)

Analysis of Factors That Interrupt With INR Control in the First Anticoagulation Clinic Monitoring Jordanian Patients
por: Al-Momany, Nairooz H., et al.
Publicado: (2019)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
por: Zhang, Xi, et al.
Publicado: (2023)

Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?
por: Kim, Esther, et al.
Publicado: (2016)

INR Goal Attainment and Oral Anticoagulation Knowledge of Patients Enrolled in an Anticoagulation Clinic in a Veterans Affairs Medical Center
por: Ryals, Casey A., et al.
Publicado: (2011)

Point of care testing to monitor INR control in patients with antiphospholipid syndrome
por: Masucci, Michael, et al.
Publicado: (2022)

Atomkärnans inre omprövas
por: Kullander, Sven
Publicado: (1986)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

Out‐of‐range INR results lead to increased health‐care utilization in four large anticoagulation clinics
por: Barnes, Geoffrey D, et al.
Publicado: (2018)

DxMONITOR: compiling veterinary diagnostic laboratory results.
por: Hueston, W
Publicado: (1995)

A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
por: Sølbeck, Sacha, et al.
Publicado: (2012)

The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography
por: Delgado, Graciela E., et al.
Publicado: (2019)

Implementation and Evaluation of the Clear Dx Platform for Sequencing SARS-CoV-2 Genomes in a Public Health Laboratory
por: Ramaiah, Arunachalam, et al.
Publicado: (2023)

Effects of Oral Ginger Supplementation on the INR
por: Rubin, Daniel, et al.
Publicado: (2019)

Data documenting the performance of the PT/INR line correction method for reconciling INR discrepancies between central laboratory coagulation analyzers using different thromboplastins during the evaluation of a portable Coagulometer
por: Baker, Wendy S., et al.
Publicado: (2017)

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
por: Smith, Danielle E, et al.
Publicado: (2010)

Relationship between the Occurrence of Thromboembolism and INR Measurement Interval in Low Intensity Anticoagulation after Aortic Mechanical Valve Replacement
por: Rhie, Sangho, et al.
Publicado: (2011)

Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding
por: Nagata, Naoyoshi, et al.
Publicado: (2017)

Comparison of the effects of different treatment protocols on mortality in patients presenting with an INR≥10 due to warfarin-associated over-anticoagulation
por: İslam, Mehmet Muzaffer, et al.
Publicado: (2023)

Security and cost comparison of INR self-testing and conventional hospital INR testing in patients with mechanical heart valve replacement
por: Chen, Qiu-lin, et al.
Publicado: (2015)

Metal specificity of cyanobacterial nickel-responsive repressor InrS: cells maintain zinc and copper below the detection threshold for InrS
por: Foster, Andrew W, et al.
Publicado: (2014)

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
por: Arbring, Kerstin, et al.
Publicado: (2013)

Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study
por: Bartoli‐Abdou, John K., et al.
Publicado: (2018)

Inr tracking with face-to-face and phone app
por: Hanedan, Muhammet Onur, et al.
Publicado: (2023)

INR reduction after prothrombin complex concentrate (Co-fact(©)) administration: comparison of INR outcomes in different patient categories at the emergency department
por: Roodheuvel, Floris, et al.
Publicado: (2013)

A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting
por: Rossiter, Jennifer, et al.
Publicado: (2013)

Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial
por: Refaai, Majed A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v0s03tamfvepcvssn2dthi9uff